Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Beatriz Somoza-Fernandez"'
Autor:
Rosa Romero-Jimenez, Vicente Escudero-Vilaplana, Esther Chamorro-de-Vega, Arantza Ais-Larisgoitia, Maria Elena Lobato Matilla, Beatriz Somoza-Fernandez, Paula Ruiz-Briones, Carlos Gonzalez, Ofelia Baniandres, Luis Menchén, Carmen Lobo-Rodríguez, Ana Herranz-Alonso, Maria Sanjurjo
BACKGROUND Pharmacotherapeutic management of immune-mediated inflammatory diseases (IMID) has become more complex due to the development of new treatments, such as biological therapies. Mobile health, especially apps, can provide IMID patients with g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8733e414896c6d820c9baafcdf1e8f0
https://doi.org/10.2196/preprints.36306
https://doi.org/10.2196/preprints.36306
Autor:
FJ García-Moreno, Roberto Collado-Borrell, María Olmedo, Maricela Valerio, Elena Lobato-Matilla, Beatriz Somoza-Fernandez, Ana Herranz, Juan Carlos Lopez-Bernaldo-de-Quirós, Teresa Aldámiz-Echevarría, Silvia Manrique-Rodríguez, Emilio Bouza, Sebastian Garcia-Sanchez, Irene Taladriz-Sender, RM Romero-Jiménez, Marina Machado, Paula Ruiz-Briones, Patricia Muñoz, Cecilia M. Fernández-Llamazares, Rafael Correa-Rocha, Milagros Sancho-Gonzalez, José Luis Revuelta-Herrero, Camino Sarobe-González, Alvaro Gimenez-Manzorro, CG Rodriguez-Gonzalez, Esther Chamorro-de-Vega, María Sanjurjo
Publikováno v:
Expert Review of Clinical Pharmacology
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Background: We report the long-term outcomes, changes in laboratory parameters, the incidence of secondary nosocomial infections and treatment cost of a Spanish cohort of patients with severe COVID-19 that received tocilizumab (TCZ). Methods: Retrosp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c533ed6110c4c54469cd542550b561ee
Autor:
Rosa Romero-Jimenez, Vicente Escudero-Vilaplana, Esther Chamorro-de-Vega, Arantza Ais-Larisgoitia, Elena Lobato-Matilla, Beatriz Somoza-Fernández, Paula Ruiz-Briones, Carlos González, Ofelia Baniandrés, Luis Menchén, Carmen Lobo-Rodríguez, Ana Herranz, María Sanjurjo
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundPharmacotherapeutic management of immune-mediated inflammatory diseases (IMID) has become more complex due to the development of new treatments, such as biological therapies. Mobile health, especially apps, can provide IMID patients with gr
Externí odkaz:
https://doaj.org/article/b51b42e375584dd6a4307adabfb26375
Autor:
Sebastián García-Sánchez, Beatriz Somoza-Fernández, Ana de Lorenzo-Pinto, Cristina Ortega-Navarro, Ana Herranz-Alonso, María Sanjurjo
Publikováno v:
JMIR mHealth and uHealth, Vol 10, Iss 4, p e29985 (2022)
BackgroundDrug-referencing apps are among the most frequently used by emergency health professionals. To date, no study has analyzed the quantity and quality of apps that provide information on emergency drugs. ObjectiveThis study aimed to identify
Externí odkaz:
https://doaj.org/article/d0c4f15b154442f19e96868c62532687